Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH‐II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. - Grundker,C.; Schlotawa,L.; Viereck,V.; Eicke,N.; Horst,A.; Kairies,B. (Eur J Endocrinol, 2004)